https://www.selleckchem.com/pr....oducts/rimiducid-ap1
Retrospective studies seem to suggest that withdrawal of anticoagulation could be safe in certain patients with APS, especially in those with a first provoked venous thrombosis and whose aPL became persistently negative during follow-up. Still, before the withdrawal can be recommended in routine clinical practice, multicenter and prospective studies are required to validate this hypothesis. People with cognitive impairment often need support to perform everyday-life activities. Interventions are available, but evidence-based in